PharmaShots | Incisive News in 3 Shots

Subscribe Now

Trial

Mundipharma and Cidara Present Results of Rezafungin in P-III (ReSTORE) Trial for Treatment of Candidemia or Invasive Candidiasis at ECCMID 2022

Mundipharma and Cidara Present Results of Rezafungin in P-III (ReSTORE) Trial for Treatment of Candidemia or Invasive Candidiasis...

April 25, 2022

Lilly Presents Updated Results of Retevmo (selpercatinib) in P-I/II (LIBRETTO-001) Trial for Advanced RET Fusion-Positive NSCLC at ELCC 2022

Lilly Presents Updated Results of Retevmo (selpercatinib) in P-I/II (LIBRETTO-001) Trial for Advanced RET Fusion-Positive NSCLC at...

April 1, 2022

Abivax Reports One-Year Maintenance Results of ABX464 in P-IIa Trial for the Treatment with Rheumatoid Arthritis

Abivax Reports One-Year Maintenance Results of ABX464 in P-IIa Trial for the Treatment with Rheumatoid Arthritis

March 10, 2022

Arcutis Reports Completion of Patient Enrollment for Roflumilast in P-III (STRATUM) Trial for the Treatment of Seborrheic Dermatitis

Arcutis Reports Completion of Patient Enrollment for Roflumilast in P-III (STRATUM) Trial for the Treatment of Seborrheic Dermatit...

February 2, 2022

Kiniksa Reports Results of Mavrilimumab in P-III Trial for the Treatment of COVID-19-Related ARDS

Kiniksa Reports Results of Mavrilimumab in P-III Trial for the Treatment of COVID-19-Related ARDS

December 29, 2021

AstraZeneca Presents Results of Calquence in the P-III (ASCEND) Trial for the Treatment of Chronic Lymphocytic Leukaemia at ASH 2021

AstraZeneca Presents Results of Calquence in the P-III (ASCEND) Trial for the Treatment of Chronic Lymphocytic Leukaemia at ASH 20...

December 13, 2021

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us